Trial of Computerized MET for Adolescent Substance Use

Boston Children's Hospital

Status and phase: Withdrawn; Phase 1

Conditions: Nicotine Dependence; Alcohol Abuse; Drug Abuse

Treatments: Behavioral: iMET; Behavioral: MET

Study type: Interventional

Funder types: Other

Identifiers

NCT01784653

SKH R01 PA-13-077

Details and patient eligibility

About

The purpose of this study is to test the effects of a computerized, self-directed Motivational Enhancement Therapy program for adolescent substance use (iMET), in comparison to clinician-delivered MET and Treatment As Usual (TAU), on treatment engagement and substance use. The investigators hypothesize that both iMET and MET will be more effective than TAU in engaging/retaining patients in treatment and in reducing substance use during a 12-month follow-up period. The investigators also hypothesize that Self-directed iMET will be as effective as the clinician-guided MET in increasing treatment engagement and abstinence during the 12-months follow-up period.

Sex: All

Ages: 12 to 21 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• completed initial visit at the treatment program;
• be available to return for iMET/MET sessions (if assigned)
• be available to complete all follow-up measurements
• a past-12-month CRAFFT score >1
• have used substances on >6 days (not including tobacco use) during the 90 days preceding their visit

Exclusion criteria

• unable to speak and understand English, or read English at a 5th grade reading level
• youth deemed by the clinical team to require immediate hospitalization or referral to more intensive residential treatment

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

0 participants in 3 patient groups

Treatment as Usual

No Intervention group

Description:

Patients will receive the usual care from the treatment program

iMET

Experimental group

Description:

Participants will complete a self-guided computerized Motivational Enhancement Therapy

Treatment:

Behavioral: iMET

MET

Experimental group

Description:

Clinician-delivered Motivational Enhancement Therapy

Treatment:

Behavioral: MET